ArticleJournal of Cancer2024

STAT3 inhibitor Stattic Exhibits the Synergistic Effect with FGFRs Inhibitor Erdafitinib in FGFR1-positive Lung Squamous Cell Carcinoma.

Hongqin Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.